United States Biotechnology & Medical Research

Fennec Pharmaceuticals Inc (FENC)

Track

Track

Fennec Pharmaceuticals experienced significant insider trading activity over the past ninety days, totaling twenty transactions. While executives engaged in notable selling, recent October buying by senior officers suggests varied sentiment. The stock price rose 13.6% recently, following a strong August earnings report where the company beat expectations by 400%.
Ticker: FENC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Fennec Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Sayad, Pierre Senior Officer of Issuer Officer
Transaction date
Purchase
Price
481.88
Quantity 59,084 +26.7%
Value US$4,842,030
3.2
Hackman, Jeffrey Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
481.15
Quantity 21,125 +29.7%
Value US$3,060,936
Evans, Terry Senior Officer of Issuer Officer
Transaction date
Purchase
Price
423.46
Quantity 59,721 -35.5%
Value US$4,453,572
Cioffi, Christiana Senior Officer of Issuer Officer
Transaction date
Purchase
Price
5.53
Quantity 1,000 +15.9%
Value US$100,000
3.7
Andrade, Robert Christopher Senior Officer of Issuer Officer
Transaction date
Purchase
Price
5.53
Quantity 1,000 +1.6%
Value US$100,000
Brughera, Marco Director of Issuer Non-Executive Director
Transaction date
Sale
Price
10.29
Quantity 15,545
Value US$159,958
Brughera, Marco Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.11
Quantity 15,545
Value US$32,800
Brughera Marco Maria Non-Executive Director
Transaction date
Planned sale
Price
10.29
Quantity 15,545 -100.0%
Value US$159,958
MARCO BRUGHERA Director Non-Executive Director
Transaction date
Proposed sale
Price
10.30
Quantity 15,545
Value US$160,070
Sayad, Pierre Senior Officer of Issuer Officer
Transaction date
Sale
Price
12.18
Quantity 12,000 -55.8%
Value US$146,160
2.7
ROSTISLAV RAYKOV Former Director Non-Executive Director
Transaction date
Proposed sale
Price
12.12
Quantity 10,000
Value US$121,177
2.7
Raykov Rosty
Transaction date
Planned sale
Price
12.11
Quantity 10,000 -7.4%
Value US$121,100
Sayad Pierre Sargis Chief Medical Officer Officer
Transaction date
Sale
Price
12.18
Quantity 12,000 -55.8%
Value US$146,160
PIERRE S SAYAD Officer Officer
Transaction date
Proposed sale
Price
12.18
Quantity 12,000
Value US$146,170
3.7
Andrade, Robert Christopher Senior Officer of Issuer Officer
Transaction date
Purchase
Price
5.10
Quantity 21,928 +10.1%
Value US$111,833
3.7
Andrade, Robert Christopher Senior Officer of Issuer Officer
Transaction date
Sale
Price
11.79
Quantity 106,844 -32.9%
Value US$1,259,691
Andrade Robert CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
11.78
Quantity 75,000 -25.6%
Value US$883,500
ROBERT ANDRADE Officer Officer
Transaction date
Proposed sale
Price
11.79
Quantity 75,000
Value US$883,898
2.7
Raykov Rosty
Transaction date
Planned sale
Price
9.58
Quantity 10,000 -7.1%
Value US$95,800
2.7
ROSTISLAV RAYKOV Former Director Non-Executive Director
Transaction date
Proposed sale
Price
9.58
Quantity 10,000
Value US$95,835
2.7
Raykov Rosty
Transaction date
Planned sale
Price
10.41
Quantity 9,599 -6.5%
Value US$99,926
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
10.42
Quantity 9,599
Value US$99,987
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Sale
Price
9.62
Quantity 9,747 -0.4%
Value US$93,766
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.45
Quantity 15,597 +0.6%
Value US$38,213
2.7
Raykov Rosty Non-Executive Director
Transaction date
Planned sale
Price
9.62
Quantity 9,747 -7.0%
Value US$93,766
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
9.62
Quantity 9,747
Value US$93,814
2.9
RALLIS CHRIS A Non-Executive Director
Transaction date
Sale
Price
7.04
Quantity 8,346 -11.7%
Value US$58,756
2.8
Rallis, Chris Anigeron Director of Issuer Non-Executive Director
Transaction date
Sale
Price
7.05
Quantity 8,346 -12.0%
Value US$58,839
2.8
Rallis, Chris Anigeron Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.44
Quantity 14,344 +25.9%
Value US$34,999
2.9
CHRIS A RALLIS Director Non-Executive Director
Transaction date
Proposed sale
Price
7.05
Quantity 8,346
Value US$58,833
2.7
Raykov Rosty Non-Executive Director
Transaction date
Planned sale
Price
6.47
Quantity 10,781 -8.2%
Value US$69,753
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
6.47
Quantity 10,781
Value US$69,762
2.7
Raykov Rosty Non-Executive Director
Transaction date
Planned sale
Price
6.31
Quantity 10,946 -8.8%
Value US$69,069
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Sale
Price
6.31
Quantity 10,946 -0.4%
Value US$69,069
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.45
Quantity 15,598 +0.6%
Value US$38,215
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
6.31
Quantity 10,946
Value US$69,073
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Sale
Price
8.37
Quantity 10,079 -0.4%
Value US$84,361
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.45
Quantity 15,598 +0.6%
Value US$38,215
2.7
Raykov Rosty Non-Executive Director
Transaction date
Sale
Price
8.36
Quantity 10,079 -8.8%
Value US$84,260
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
8.37
Quantity 10,079
Value US$84,354
3.7
Andrade, Robert Christopher Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.08
Quantity 2,450 +1.0%
Value US$9,996
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
7.76
Quantity 10,349
Value US$80,339
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Sale
Price
7.76
Quantity 10,439
Value US$81,007
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.45
Quantity 15,598 +0.6%
Value US$38,215
2.7
Raykov Rosty Non-Executive Director
Transaction date
Sale
Price
7.76
Quantity 10,349 -9.5%
Value US$80,308
3.7
Andrade, Robert Christopher Senior Officer of Issuer Officer
Transaction date
Purchase
Price
2.45
Quantity 10,000 +4.1%
Value US$24,500
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Sale
Price
7.61
Quantity 10,312 -0.4%
Value US$78,474
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.45
Quantity 15,598 +0.6%
Value US$38,215
2.7
Raykov Rosty Non-Executive Director
Transaction date
Sale
Price
7.60
Quantity 10,312 -10.5%
Value US$78,371
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
7.61
Quantity 10,312
Value US$78,471
3.2
Southpoint Capital Advisors LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
7.50
Quantity 1,000,000 -26.7%
Value US$7,500,000
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
7.54
Quantity 10,000
Value US$75,444
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Sale
Price
7.54
Quantity 10,000 -0.4%
Value US$75,400
2.7
Raykov Rosty Non-Executive Director
Transaction date
Planned sale
Price
7.54
Quantity 10,000 -11.4%
Value US$75,400
3.2
Southpoint Capital Advisors LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
8.79
Quantity 19,341 -0.5%
Value US$170,048
3.2
Southpoint Capital Advisors LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
8.79
Quantity 85,918 -2.2%
Value US$755,193
3.2
Southpoint Capital Advisors LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
8.00
Quantity 160,100 -4.0%
Value US$1,280,432
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Sale
Price
8.10
Quantity 10,000 -0.4%
Value US$81,000
2.7
Raykov Rosty Non-Executive Director
Transaction date
Planned sale
Price
8.10
Quantity 10,000 -10.8%
Value US$81,000
2.7
ROSTISLAV RAYKOV Director Non-Executive Director
Transaction date
Proposed sale
Price
8.11
Quantity 10,000
Value US$81,082
2.9
RALLIS CHRIS A Non-Executive Director
Transaction date
Sale
Price
9.24
Quantity 1,775 -3.0%
Value US$16,401
2.9
CHRIS A RALLIS Director Non-Executive Director
Transaction date
Proposed sale
Price
9.24
Quantity 1,775
Value US$16,401
2.8
Rallis, Chris Anigeron Director of Issuer Non-Executive Director
Transaction date
Sale
Price
9.24
Quantity 1,775 -3.1%
Value US$16,401
2.8
Rallis, Chris Anigeron Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
1.23
Quantity 4,062 +7.7%
Value US$4,996
3.2
Southpoint Capital Advisors LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
9.35
Quantity 20,609 -0.5%
Value US$192,614
3.2
Southpoint Capital Advisors LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
9.47
Quantity 19,605 -0.5%
Value US$185,663
3.1
Raykov, Rostislav Christov Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.45
Quantity 4,609 +0.2%
Value US$11,292
3.2
Southpoint Capital Advisors LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
9.59
Quantity 26,900 -0.7%
Value US$257,893
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-14 2026-10-12 B Purchase
Sayad, Pierre

Senior Officer of Issuer

Officer
59,084 +26.7%
481.88
US$4,842,030 		59,084 +26.7% 481.88 US$4,842,030
2026-10-14 2026-10-12 B Purchase
3.2
Hackman, Jeffrey

Director of Issuer, Senior Officer of Issuer

Executive Director
21,125 +29.7%
481.15
US$3,060,936 		21,125 +29.7% 481.15 US$3,060,936
2026-10-14 2026-10-12 B Purchase
Evans, Terry

Senior Officer of Issuer

Officer
59,721 -35.5%
423.46
US$4,453,572 		59,721 -35.5% 423.46 US$4,453,572
2026-10-14 2026-10-12 B Purchase
Cioffi, Christiana

Senior Officer of Issuer

Officer
1,000 +15.9%
5.53
US$100,000 		1,000 +15.9% 5.53 US$100,000
2026-10-14 2026-10-12 B Purchase
3.7
Andrade, Robert Christopher

Senior Officer of Issuer

Officer
1,000 +1.6%
5.53
US$100,000 		1,000 +1.6% 5.53 US$100,000
2026-09-18 2026-09-15 S Sale
Brughera, Marco

Director of Issuer

Non-Executive Director
15,545
10.29
US$159,958 		15,545 10.29 US$159,958
2026-09-18 2026-09-15 B Purchase
Brughera, Marco

Director of Issuer

Non-Executive Director
15,545
2.11
US$32,800 		15,545 2.11 US$32,800
2026-09-16 2026-09-15 PlS Planned sale
Brughera Marco Maria
Non-Executive Director
15,545 -100.0%
10.29
US$159,958 		15,545 -100.0% 10.29 US$159,958
2026-09-15 2026-09-15 PrS Proposed sale
MARCO BRUGHERA

Director

Non-Executive Director
15,545
10.30
US$160,070 		15,545 10.30 US$160,070
2026-09-08 2026-09-04 S Sale
Sayad, Pierre

Senior Officer of Issuer

Officer
12,000 -55.8%
12.18
US$146,160 		12,000 -55.8% 12.18 US$146,160
2026-09-01 2026-09-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Former Director

Non-Executive Director
10,000
12.12
US$121,177 		10,000 12.12 US$121,177
2026-09-01 2026-09-01 PlS Planned sale
2.7
Raykov Rosty
10,000 -7.4%
12.11
US$121,100 		10,000 -7.4% 12.11 US$121,100
2026-08-31 2026-08-31 S Sale
Sayad Pierre Sargis

Chief Medical Officer

Officer
12,000 -55.8%
12.18
US$146,160 		12,000 -55.8% 12.18 US$146,160
2026-08-31 2026-08-31 PrS Proposed sale
PIERRE S SAYAD

Officer

Officer
12,000
12.18
US$146,170 		12,000 12.18 US$146,170
2026-08-28 2026-08-28 B Purchase
3.7
Andrade, Robert Christopher

Senior Officer of Issuer

Officer
21,928 +10.1%
5.10
US$111,833 		21,928 +10.1% 5.10 US$111,833
2026-08-28 2026-08-27 S Sale
3.7
Andrade, Robert Christopher

Senior Officer of Issuer

Officer
106,844 -32.9%
11.79
US$1,259,691 		106,844 -32.9% 11.79 US$1,259,691
2026-08-28 2026-08-27 PlS Planned sale
Andrade Robert

CHIEF FINANCIAL OFFICER

Officer
75,000 -25.6%
11.78
US$883,500 		75,000 -25.6% 11.78 US$883,500
2026-08-27 2026-08-27 PrS Proposed sale
ROBERT ANDRADE

Officer

Officer
75,000
11.79
US$883,898 		75,000 11.79 US$883,898
2026-08-04 2026-08-03 PlS Planned sale
2.7
Raykov Rosty
10,000 -7.1%
9.58
US$95,800 		10,000 -7.1% 9.58 US$95,800
2026-08-03 2026-08-03 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Former Director

Non-Executive Director
10,000
9.58
US$95,835 		10,000 9.58 US$95,835
2026-07-02 2026-07-01 PlS Planned sale
2.7
Raykov Rosty
9,599 -6.5%
10.41
US$99,926 		9,599 -6.5% 10.41 US$99,926
2026-07-01 2026-07-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
9,599
10.42
US$99,987 		9,599 10.42 US$99,987
2026-06-04 2026-06-01 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
9,747 -0.4%
9.62
US$93,766 		9,747 -0.4% 9.62 US$93,766
2026-06-04 2026-06-01 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,597 +0.6%
2.45
US$38,213 		15,597 +0.6% 2.45 US$38,213
2026-06-02 2026-06-01 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
9,747 -7.0%
9.62
US$93,766 		9,747 -7.0% 9.62 US$93,766
2026-06-01 2026-06-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
9,747
9.62
US$93,814 		9,747 9.62 US$93,814
2026-05-12 2026-05-11 S Sale
2.9
RALLIS CHRIS A
Non-Executive Director
8,346 -11.7%
7.04
US$58,756 		8,346 -11.7% 7.04 US$58,756
2026-05-11 2026-05-11 S Sale
2.8
Rallis, Chris Anigeron

Director of Issuer

Non-Executive Director
8,346 -12.0%
7.05
US$58,839 		8,346 -12.0% 7.05 US$58,839
2026-05-11 2026-05-11 B Purchase
2.8
Rallis, Chris Anigeron

Director of Issuer

Non-Executive Director
14,344 +25.9%
2.44
US$34,999 		14,344 +25.9% 2.44 US$34,999
2026-05-11 2026-05-11 PrS Proposed sale
2.9
CHRIS A RALLIS

Director

Non-Executive Director
8,346
7.05
US$58,833 		8,346 7.05 US$58,833
2026-05-01 2026-05-01 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,781 -8.2%
6.47
US$69,753 		10,781 -8.2% 6.47 US$69,753
2026-05-01 2026-05-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,781
6.47
US$69,762 		10,781 6.47 US$69,762
2026-04-02 2026-04-01 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,946 -8.8%
6.31
US$69,069 		10,946 -8.8% 6.31 US$69,069
2026-04-01 2026-04-01 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,946 -0.4%
6.31
US$69,069 		10,946 -0.4% 6.31 US$69,069
2026-04-01 2026-04-01 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,598 +0.6%
2.45
US$38,215 		15,598 +0.6% 2.45 US$38,215
2026-04-01 2026-04-01 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,946
6.31
US$69,073 		10,946 6.31 US$69,073
2026-03-03 2026-03-02 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,079 -0.4%
8.37
US$84,361 		10,079 -0.4% 8.37 US$84,361
2026-03-03 2026-03-02 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,598 +0.6%
2.45
US$38,215 		15,598 +0.6% 2.45 US$38,215
2026-03-03 2026-03-02 S Sale
2.7
Raykov Rosty
Non-Executive Director
10,079 -8.8%
8.36
US$84,260 		10,079 -8.8% 8.36 US$84,260
2026-03-02 2026-03-02 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,079
8.37
US$84,354 		10,079 8.37 US$84,354
2026-02-24 2026-02-19 B Purchase
3.7
Andrade, Robert Christopher

Senior Officer of Issuer

Officer
2,450 +1.0%
4.08
US$9,996 		2,450 +1.0% 4.08 US$9,996
2026-02-02 2026-02-02 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,349
7.76
US$80,339 		10,349 7.76 US$80,339
2026-02-02 2026-02-02 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,439
7.76
US$81,007 		10,439 7.76 US$81,007
2026-02-02 2026-02-02 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,598 +0.6%
2.45
US$38,215 		15,598 +0.6% 2.45 US$38,215
2026-02-02 2026-02-02 S Sale
2.7
Raykov Rosty
Non-Executive Director
10,349 -9.5%
7.76
US$80,308 		10,349 -9.5% 7.76 US$80,308
2026-01-16 2026-01-14 B Purchase
3.7
Andrade, Robert Christopher

Senior Officer of Issuer

Officer
10,000 +4.1%
2.45
US$24,500 		10,000 +4.1% 2.45 US$24,500
2026-01-05 2026-01-02 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,312 -0.4%
7.61
US$78,474 		10,312 -0.4% 7.61 US$78,474
2026-01-05 2026-01-02 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
15,598 +0.6%
2.45
US$38,215 		15,598 +0.6% 2.45 US$38,215
2026-01-05 2026-01-02 S Sale
2.7
Raykov Rosty
Non-Executive Director
10,312 -10.5%
7.60
US$78,371 		10,312 -10.5% 7.60 US$78,371
2026-01-02 2026-01-02 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,312
7.61
US$78,471 		10,312 7.61 US$78,471
2025-12-29 2025-12-24 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
1,000,000 -26.7%
7.50
US$7,500,000 		1,000,000 -26.7% 7.50 US$7,500,000
2025-12-24 2025-12-24 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
1,000,000 -26.7%
7.50
US$7,500,000 		1,000,000 -26.7% 7.50 US$7,500,000
2025-12-05 2025-12-05 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
7.54
US$75,444 		10,000 7.54 US$75,444
2025-12-05 2025-12-05 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,000 -0.4%
7.54
US$75,400 		10,000 -0.4% 7.54 US$75,400
2025-12-05 2025-12-05 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -11.4%
7.54
US$75,400 		10,000 -11.4% 7.54 US$75,400
2025-12-24 2025-11-18 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
19,341 -0.5%
8.79
US$170,048 		19,341 -0.5% 8.79 US$170,048
2025-11-20 2025-11-18 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
19,341 -0.5%
8.79
US$170,048 		19,341 -0.5% 8.79 US$170,048
2025-11-18 2025-11-17 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
85,918 -2.2%
8.79
US$755,193 		85,918 -2.2% 8.79 US$755,193
2025-11-17 2025-11-17 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
85,918 -2.2%
8.79
US$755,193 		85,918 -2.2% 8.79 US$755,193
2025-11-18 2025-11-14 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
160,100 -4.0%
8.00
US$1,280,432 		160,100 -4.0% 8.00 US$1,280,432
2025-11-17 2025-11-14 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
160,100 -4.0%
8.00
US$1,280,432 		160,100 -4.0% 8.00 US$1,280,432
2025-11-06 2025-11-05 S Sale
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
10,000 -0.4%
8.10
US$81,000 		10,000 -0.4% 8.10 US$81,000
2025-11-06 2025-11-05 PlS Planned sale
2.7
Raykov Rosty
Non-Executive Director
10,000 -10.8%
8.10
US$81,000 		10,000 -10.8% 8.10 US$81,000
2025-11-05 2025-11-05 PrS Proposed sale
2.7
ROSTISLAV RAYKOV

Director

Non-Executive Director
10,000
8.11
US$81,082 		10,000 8.11 US$81,082
2025-10-14 2025-10-10 S Sale
2.9
RALLIS CHRIS A
Non-Executive Director
1,775 -3.0%
9.24
US$16,401 		1,775 -3.0% 9.24 US$16,401
2025-10-10 2025-10-10 PrS Proposed sale
2.9
CHRIS A RALLIS

Director

Non-Executive Director
1,775
9.24
US$16,401 		1,775 9.24 US$16,401
2025-10-10 2025-10-10 S Sale
2.8
Rallis, Chris Anigeron

Director of Issuer

Non-Executive Director
1,775 -3.1%
9.24
US$16,401 		1,775 -3.1% 9.24 US$16,401
2025-10-10 2025-10-10 B Purchase
2.8
Rallis, Chris Anigeron

Director of Issuer

Non-Executive Director
4,062 +7.7%
1.23
US$4,996 		4,062 +7.7% 1.23 US$4,996
2025-10-10 2025-10-09 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
20,609 -0.5%
9.35
US$192,614 		20,609 -0.5% 9.35 US$192,614
2025-10-09 2025-10-09 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
20,609 -0.5%
9.35
US$192,614 		20,609 -0.5% 9.35 US$192,614
2025-10-10 2025-10-08 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
19,605 -0.5%
9.47
US$185,663 		19,605 -0.5% 9.47 US$185,663
2025-10-10 2025-10-08 B Purchase
3.1
Raykov, Rostislav Christov

Director of Issuer

Non-Executive Director
4,609 +0.2%
2.45
US$11,292 		4,609 +0.2% 2.45 US$11,292
2025-10-09 2025-10-08 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
19,605 -0.5%
9.47
US$185,722 		19,605 -0.5% 9.47 US$185,722
2025-10-10 2025-10-07 S Sale
3.2
Southpoint Capital Advisors LP

10% Security Holder of Issuer

Large shareholder
26,900 -0.7%
9.59
US$257,893 		26,900 -0.7% 9.59 US$257,893
2025-10-09 2025-10-07 S Sale
3.4
Southpoint Capital Advisors LP
Large shareholder
26,900 -0.7%
9.59
US$257,893 		26,900 -0.7% 9.59 US$257,893
Explore more

More insider trading research around Fennec Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America